Translational control of furina by an RNA regulon is important for left-right patterning, heart morphogenesis and cardiac valve function

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 11,7 MB, PDF-dokument

  • Agnieszka Nagorska
  • Andreas Zaucker
  • Finnlay Lambert
  • Angus Inman
  • Sara Toral-Perez
  • Gorodkin, Jan
  • Yue Wan
  • Michael Smutny
  • Karuna Sampath

Heart development is a complex process that requires asymmetric positioning of the heart, cardiac growth and valve morphogenesis. The mechanisms controlling heart morphogenesis and valve formation are not fully understood. The pro-convertase FurinA functions in heart development across vertebrates. How FurinA activity is regulated during heart development is unknown. Through computational analysis of the zebrafish transcriptome, we identified an RNA motif in a variant FurinA transcript harbouring a long 3′ untranslated region (3′UTR). The alternative 3′UTR furina isoform is expressed prior to organ positioning. Somatic deletions in the furina 3′UTR lead to embryonic left-right patterning defects. Reporter localisation and RNA-binding assays show that the furina 3′UTR forms complexes with the conserved RNA-binding translational repressor, Ybx1. Conditional ybx1 mutant embryos show premature and increased Furin reporter expression, abnormal cardiac morphogenesis and looping defects. Mutant ybx1 hearts have an expanded atrioventricular canal, abnormal sino-atrial valves and retrograde blood flow from the ventricle to the atrium. This is similar to observations in humans with heart valve regurgitation. Thus, the furina 3′UTR element/Ybx1 regulon is important for translational repression of FurinA and regulation of heart development.

OriginalsprogEngelsk
Artikelnummer201657
TidsskriftDevelopment (Cambridge)
Vol/bind150
Udgave nummer23
Antal sider15
ISSN0950-1991
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
A.N. was supported by a Warwick Medical School doctoral scholarship and a Medical and Life Sciences Research Fund (MLSRF) research award. A.Z. and ST-P were supported by the Leverhulme Trust and the Warwick-Wellcome Quantitative Biomedicine Programme (funded by the Wellcome Institutional Strategic Support Fund). F.L. was supported by the University of Warwick and A*STAR Singapore Warwick-ARAP doctoral programme. A.I. was supported by the MRC-DTP (Medical Research Council Doctoral Training Partnership). W.Y. is supported by A*STAR (Agency for Science, Technology and Research) Singapore. M.S. is supported by Warwick Medical School and UKRI BBSRC (UK Research and Innovation/ Biotechnology and Biological Sciences Research Council). J.G. is supported by the Innovation Fund Denmark (Innovationsfonden). Work in the K.S. laboratory is supported by the Leverhulme Trust and the UKRI BBSRC. Open access funding provided by the University of Warwick. Deposited in PMC for immediate release.

Publisher Copyright:
© 2023. Published by The Company of Biologists Ltd.

ID: 384495555